India Insight

Budget 2014: Biocon chief wants more R&D incentives, fewer essential drugs

July 4, 2014

India’s $15 billion healthcare industry has taken hits on several fronts in recent years, from slow approvals for drugs in clinical trials to several run-ins with the U.S. Food and Drug Administration over the quality of its generic drugs.

Biocon chief Kiran Mazumdar-Shaw among Asia-Pacific’s biggest givers

May 30, 2013

Biocon chief Kiran Mazumdar-Shaw and Bollywood mogul Ronnie Screwvala are among the most generous people in the Asia Pacific, according to a Forbes Asia list of the region’s philanthropic heroes.